Cabergoline
卡麦角林
Report date: 2026/03/26 20:00:17
NME
Base Information
Drug NameCabergoline
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[17]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1992/01/01
Country/Territory +[7]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesTanta UniversityNorwegian University Of Science And TechnologyBangabandhu Sheikh Mujib Medical University +[7]
Inactive CompaniesPfizer IncBenha UniversityNational Institute On Drug Abuse +[7]
Active Indications +[9]
Inactive Indications +[8]